€60.20
1.31% today
Frankfurt, Nov 21, 08:47 am CET
ISIN
NL0012044747
Symbol
RDC
Index

Redcare Pharmacy Stock price

€61.00
-24.25 28.45% 1M
-67.30 52.46% 6M
-71.70 54.03% YTD
-87.10 58.81% 1Y
+18.60 43.87% 3Y
-73.40 54.61% 5Y
+32.50 114.04% 10Y
+32.50 114.04% 20Y
Frankfurt, Closing price Thu, Nov 20 2025
-2.20 3.48%
ISIN
NL0012044747
Symbol
RDC
Index

New AI Insights on Redcare Pharmacy Insights AI Insights on Redcare Pharmacy

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
€1.3b
Enterprise Value
€1.4b
Net debt
€121.1m
Cash
€271.3m
Shares outstanding
20.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
negative
P/B
2.6
Financial Health
Equity Ratio
48.2%
Return on Equity
-9.4%
ROCE
-3.9%
ROIC
-4.1%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
€2.8b | €3.0b
EBITDA
€36.4m | €64.1m
EBIT
€-32.6m | €-12.4m
Net Income
€-35.2m | €-19.5m
Free Cash Flow
€-61.5m
Growth (TTM | estimate)
Revenue
26.7% | 27.1%
EBITDA
-27.4% | 115.2%
EBIT
-72.1% | 67.6%
Net Income
-43.3% | 57.1%
Free Cash Flow
-483.8%
Margin (TTM | estimate)
Gross
22.9%
EBITDA
1.3% | 2.1%
EBIT
-1.2%
Net
-1.3% | -0.7%
Free Cash Flow
-2.2%
More
EPS
€-1.7
FCF per Share
€-3.0
Short interest
-
Employees
2k
Rev per Employee
€1.3m
Show more

Is Redcare Pharmacy a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Redcare Pharmacy Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Redcare Pharmacy forecast:

11x Buy
73%
2x Hold
13%
2x Sell
13%

Analyst Opinions

15 Analysts have issued a Redcare Pharmacy forecast:

Buy
73%
Hold
13%
Sell
13%

Financial data from Redcare Pharmacy

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,821 2,821
27% 27%
100%
- Direct Costs 2,175 2,175
27% 27%
77%
645 645
25% 25%
23%
- Selling and Administrative Expenses 678 678
27% 27%
24%
- Research and Development Expense - -
-
-
36 36
27% 27%
1%
- Depreciation and Amortization 69 69
0% 0%
2%
EBIT (Operating Income) EBIT -33 -33
72% 72%
-1%
Net Profit -35 -35
43% 43%
-1%

In millions EUR.

Don't miss a Thing! We will send you all news about Redcare Pharmacy directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Redcare Pharmacy Stock News

AD HOC NEWS
4 days ago
Redcare Pharmacy N.V. / NL0012044747
AD HOC NEWS
10 days ago
Die Schweizer Großbank UBS hat das Kursziel für Redcare Pharmacy NL0012044747 zwar von 82 auf 74 Euro gesenkt, die Aktien aber von "Sell" auf "Neutral" hochgestuft.
AD HOC NEWS
10 days ago
Veränderungen im Vorstand bei der Online-Apotheke Redcare Pharmacy NL0012044747: Hendrik Krampe soll mit Wirkung zum 1.
More Redcare Pharmacy News

Company Profile

Shop Apotheke Europe NV engages in the provision of medication and pharmacy-related beauty and care products. It operates through the DACH and International geographical segments. The DACH segment sells prescription medicine, prescription-free pharmaceuticals, and beauty and personal care products, and functional food products to individual customers located in the German, the Austrian, and the Swiss market. The International segment trades pharmaceutical products outside European market. The company was founded by Stephan Weber and Marc Fischer in 2001 and is headquartered in Venlo, the Netherlands.

Head office Netherlands
CEO Olaf Heinrich
Employees 1,827
Founded 2001
Website www.redcare-pharmacy.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today